Related Experiment Video
Updated: Nov 25, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis
Fabrizio Fabrizi1, Carlo M Alfieri1,2, Roberta Cerutti1
1Division of Nephrology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.
Insights
Acute kidney injury (AKI) is a frequent complication in hospitalized COVID-19 patients, affecting 15.4% of cases. Older age and hypertension increase AKI risk, which is significantly higher in deceased patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic with significant morbidity and mortality.
- Preliminary evidence indicates acute kidney injury (AKI) is an uncommon but serious complication in COVID-19 patients.
- AKI in COVID-19 is associated with poorer patient outcomes, necessitating further investigation.
Purpose of the Study:
- To systematically review and meta-analyze clinical studies on the frequency of AKI in hospitalized COVID-19 patients.
- To evaluate the incidence of AKI and the requirement for renal replacement therapy (RRT) in this population.
- To assess the relationship between AKI and mortality risk in COVID-19 patients.
Main Methods:
- A systematic literature review and meta-analysis of clinical studies were performed.
- Data from 39 studies encompassing 25,566 unique COVID-19 patients were analyzed.
- The DerSimonian and Laird random-effects model was used, incorporating heterogeneity and stratified analyses.
Main Results:
- The pooled incidence of AKI across studies was 15.4% (95% CI, 10.7%-20.1%), with significant heterogeneity observed.
- The overall frequency of RRT in COVID-19 patients was 4.3% (95% CI, 3.1%-5.5%).
- AKI incidence was higher in severe COVID-19 cases (53%) and strongly associated with mortality (OR 15.4). Age and arterial hypertension were identified as risk factors for AKI.
Conclusions:
- Acute kidney injury (AKI) is a common and significant complication in hospitalized patients with COVID-19.
- The findings highlight the increased risk of AKI and its association with mortality in this patient group.
- Further research is warranted to elucidate the mechanisms of kidney injury in COVID-19 and to develop targeted interventions.
Background:
coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)-is an ongoing pandemic with high morbidity and mortality rates. Preliminary evidence suggests that acute kidney injury (AKI) is uncommon in patients with COVID-19 and associated with poor outcomes. Study aims and design: we performed a systematic review of the literature with a meta-analysis of clinical studies to evaluate the frequency of AKI and dialysis requirement in patients who underwent hospitalization due to COVID-19. The incidence of AKI according to the death risk was calculated in these patients. The random-effects model of DerSimonian and Laird was adopted, with heterogeneity and stratified analyses.
Results:
thirty-nine clinical studies (n = 25,566 unique patients) were retrieved. The pooled incidence of AKI was 0.154 (95% CI, 0.107; 0.201; p < 0.0001) across the studies. Significant heterogeneity was found (p = 0.0001). The overall frequency of COVID-19-positive patients who underwent renal replacement therapy (RRT) was 0.043 (95% CI, 0.031; 0.055; p < 0.0001); no publication bias was found (Egger's test, p = 0.11). The pooled estimate of AKI incidence in patients with severe COVID-19 was 0.53 (95% CI, 0.427; 0.633) and heterogeneity occurred (Q = 621.08, I2 = 97.26, p = 0.0001). According to our meta-regression, age (p < 0.007) and arterial hypertension (p < 0.001) were associated with AKI occurrence in hospitalized COVID-19 positive patients. The odds ratio (OR) for the incidence of AKI in deceased COVID-19 positive patients was greater than among survivors, 15.4 (95% CI, 20.99; 11.4; p < 0.001).
Conclusions:
AKI is a common complication in hospitalized COVID-19 positive patients. Additional studies are under way to assess the risk of AKI in COVID-19 patients and to deepen the mechanisms of kidney injury.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

